← Back to Clinical Trials
Recruiting NCT07691385

NCT07691385 Prevention of Pain Induced During Bed Bath in Ehpad

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07691385
Status Recruiting
Phase
Sponsor Hôpital NOVO
Condition Geriatric Care
Study Type INTERVENTIONAL
Enrollment 12 participants
Start Date 2026-07-06
Primary Completion 2027-10-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Standard personal hygieneAdapted toilet

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 12 participants in total. It began in 2026-07-06 with a primary completion date of 2027-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Residents of long-term care facilities are subjected to procedures and treatments that may be painful. The prevalence is 90% among older adults living in institutions. Preventing procedure-induced pain is essential, as the consequences can be even more harmful. Induced pain is defined as "short-term pain caused by a healthcare provider, treatment, or care, under predictable circumstances," according to the UPSA Pain Institute. For these older adults, personal hygiene is performed in bed by nursing assistants and requires frequent handling and repositioning. It includes dressing and undressing, which are sources of pain. Despite this, these activities are repeated daily because they are essential. Addressing pain is a fundamental criterion for quality of life in older adults. In many cases, these residents require daily premedication with analgesics to prevent pain caused by personal care. For these residents, who are already on multiple medications, the addition of analgesics increases the risk of drug interactions, leading to more frequent side effects.

Eligibility Criteria

Inclusion Criteria: * Inclusion criteria common to all groups * Senior residents * With a stable Algoplus score of 2 or higher * Information provided to and consent obtained from the resident or their trusted representative * Eligible for intervention by a psychomotor therapist Criteria specific to Group 1: * Residents requiring high doses of analgesics (Level 3) before bathing * GIR (Iso-Resource Group) 1, with multiple medical conditions Criteria specific to Group 2: * Residents requiring Level 1 or 2 analgesics before bathing * GIR (Iso-Resource Group) 2 or 3, with multiple medical conditions Criteria specific to Group 3: * Residents experiencing pain without analgesics prior to bathing * GIR (Iso-Resource Group) 3 or 4, with multiple medical conditions Exclusion Criteria: * Resident who has previously received treatment from a psychomotor therapist * Resident capable of washing at the sink (partially) or independently * Under guardianship, conservatorship, or judicial protection

Contact & Investigator

Central Contact

Vella QUILLIEN

✉ vella.quillien@ght-novo.fr

📞 01 30 75 51 75

Principal Investigator

Vella QUIILIEN

PRINCIPAL INVESTIGATOR

Hôpital NOVO

Frequently Asked Questions

Who can join the NCT07691385 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Geriatric Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07691385 currently recruiting?

Yes, NCT07691385 is actively recruiting participants. Contact the research team at vella.quillien@ght-novo.fr for enrollment information.

Where is the NCT07691385 trial being conducted?

This trial is being conducted at Pontoise, France.

Who is sponsoring the NCT07691385 clinical trial?

NCT07691385 is sponsored by Hôpital NOVO. The principal investigator is Vella QUIILIEN at Hôpital NOVO. The trial plans to enroll 12 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology